Dr. Peter Piot is a former Director of the London School of Hygiene & Tropical Medicine and a Handa Professor of Global Health. He is a visiting professor at the Rega Institute of Biomedical Research at the Catholic University of Leuven, Belgium, and at the National University of Singapore.
He has a medical degree from the University of Ghent (1974) and a Ph.D. in Microbiology from the University of Antwerp (1980). In 1976, he co-discovered the Ebola virus in Zaire while working at the Institute of Tropical Medicine in Antwerp, Belgium; and led research on HIV/AIDS, sexually transmitted diseases, and women’s health, mostly in sub-Saharan Africa. He was a professor of microbiology and public health at the Institute of Tropical Medicine, Antwerp, and the University of Nairobi; he was a Senior Fellow at the University of Washington and at the Bill & Melinda Gates Foundation. He was the Director of the Institute for Global Health at Imperial College, London, and held the chair 2009/2010 “Knowledge against poverty” at the College de France.
He was the founding Executive Director of UNAIDS and Under-Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of WHO. Under his leadership UNAIDS became the chief advocate for worldwide action against AIDS, also spearheading UN reform by bringing together 10 UN system organizations.
He is a member of the US National Academy of Medicine and has published over 600
scientific articles and 17 books, including his memoir No Time to Lose.
Richard Whitley, M.D., is a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and Neurosurgery; Co-Director, Division of Pediatric Infectious Diseases; Senior Scientist, Department of Gene Therapy; Senior Advisor for Drug Discovery and Development and Senior Leader, Pediatric Oncology Program, O’Neal Comprehensive Cancer Center at UAB. He is also the Co-Founder and Co-Director, of the Alabama Drug Discovery Alliance.
Dr. Whitley is responsible for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group whose role is to perform clinical trials of antiviral therapies directed against medically important viral diseases of children and adults including viruses considered as threats to human health.
He received his B.A. in chemistry from Duke University and his M.D. from George Washington University. He has published more than 380 articles.